Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions

Journal of Nephrology

Volumn 19, Issue 6, 2006, Pages 758-763

  Hwang, Jyh Chang ^a   Wang, Hsiann Yih ^a   Wang, Charn Ting ^a   Chen, Hung Chun ^b  

^a Chi Mei Foundation Hospital   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Icodextrin; Peritoneal dialysis; Peritoneal equilibrium test

Indexed keywords

GLUCOSE; ICODEXTRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSATE; FEMALE; FUNCTION TEST; HUMAN; INTERMETHOD COMPARISON; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PERITONEAL EQUILIBRIUM TEST; STATISTICAL SIGNIFICANCE; ULTRAFILTRATION; VESICOURETERAL REFLUX;

ADULT; BIOLOGICAL TRANSPORT, ACTIVE; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PERITONEAL DIALYSIS; SWEETENING AGENTS;

EID: 33947251880     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Twardowski ZJ, Nolph KD, Prowant B, Ryan L, Moore H, Nieisen M, Khanna R. Peritoneal equilibrium test. Perit Dial Bull 1987; 7: 138-47.
2. Smit W, van Dijk P, Langedijk MJ, Schouten N, van den Berg N, Struijk DG, Krediet RT. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23: 440-9.
3. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46: 496-503.
4. Mistry CD, Gokal R. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis? The role for colloid osmosis. Clin Sci 1993; 85: 495-500.
5. Al-Hoqail IA, Crawford RI. Acute generalized exanthematous pustulosis induced by icodextrin. Br J Dermatol 2001; 145: 1026-7.
6. Valance A, Lebrun-Vignes B, Descamps V, Queffeulou G, Crickx B. Icodextrin cutaneous hypersensitivity: report of 3 psoriasiform cases. Arch Dermatol 2001; 137: 309-10.
7. Parikova A, Zweers MM, Struijk DG, Krediet RT. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial 2003; 19: 186-90.
8. Glorieux G, Lameire N, Van Biesen W, Dequidt C, Vanholder R. Specific characteristics of peritoneal leukocyte populations during sterile peritonitis associated with icodextrin CAPD fluids. Nephrol Dial Transplant 2003; 18: 1648-53.
9. Nishida Y, Shao JC, Kiribayashi K, Nakamura C, Yorioka N. Advanced glycation end-products reduce the viability of human peritoneal mesothelial cells. Nephron 1998; 80: 477-8.
10. Wolfson M, Piraino B, Hamburger RJ, Morton AR; Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40: 1055-65.
11. Lilaj T, Dittrich E, Puttinger H, Schneider B, Haag-Weber M, Hörl WH, Vychytil A. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results. Am J Kidney Dis 2001; 38: 118-26.
12. Martin J, Sansone G, Cirugeda A, Sanchez-Tomero JA, Munoz C, Selgas R. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis. Adv Petit Dial 2003; 19: 191-4.
13. Frajewicki V, Kushnir D, Wajsbrot V, Kohan R, Shostak A, Gotloib L. Peritoneal transport after long-term exposure to icodextrin in rats. Nephron 2002; 92: 174-82.
14. Gotloib L, Wajsbrot V, Shostak A. Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin. Nephron 2002; 92: 142-55.
15. Toure F, Lavaud S, Mohajer M, Lavaud F, Canivet E, Nguyen P, Chanard J, Rieu P. Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis. Kidney Int 2004; 65: 654-60.
16. Boer WH, Vos PF, Fieren MW. Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis. Perit Dial Int 2003; 23: 33-8.
17. Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001; 17: 80-3.
18. Lee JH, Reddy DK, Saran R, Moore HL, Twardowski ZJ, Nolph KD, Khanna R. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin. Perit Dial Int 2000; 20: S39-47,
19. Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003; 64: 1480-6.
20. de Boer AW, Schroder CH, van Vliet R, Willems JL, Monnens LA. Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism. Pediatr Nephrol 2000; 15: 21-4.
21. Ota K, Akiba T, Nakao T, Nakayama M, Maeba T, Park MS, Tranaeus A, Yorioka N; Icodextrin Study Group. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients. Perit Dial Int 2003; 23: 356-61.
22. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 1999; 14: 1530-5.